Inhaled ciclosporin offers lung function benefits to patients after lung transplantation

摘要

Lung transplant patients who receive inhaled ciclosporin have better lung function two years after surgery compared with patients given placebo.Latest data from a US trial into the novel formulation of the anti-rejection drug were presented at last week's American Thoracic Society meeting held in San Diego,California.